These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17886247)

  • 21. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.
    Johansson P; Klein-Hitpass L; Grabellus F; Arnold G; Klapper W; Pförtner R; Dührsen U; Eckstein A; Dürig J; Küppers R
    Oncotarget; 2016 Sep; 7(38):62627-62639. PubMed ID: 27566587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility.
    Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; Balsa A; Blanco FJ; Cañete JD; Caliz R; Carreño L; de la Serna AR; Fernandez-Gutierrez B; Ortiz AM; Herrero-Beaumont G; Pablos JL; Narvaez J; Navarro F; Marenco JL; Gomez-Reino JJ; Gonzalez A
    Arthritis Res Ther; 2009; 11(2):R42. PubMed ID: 19292917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
    Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
    Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.
    Moody S; Escudero-Ibarz L; Wang M; Clipson A; Ochoa Ruiz E; Dunn-Walters D; Xue X; Zeng N; Robson A; Chuang SS; Cogliatti S; Liu H; Goodlad J; Ashton-Key M; Raderer M; Bi Y; Du MQ
    J Pathol; 2017 Sep; 243(1):3-8. PubMed ID: 28682481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
    Hother C; Rasmussen PK; Joshi T; Reker D; Ralfkiær U; Workman CT; Heegaard S; Ralfkiær E; Grønbæk K
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5169-75. PubMed ID: 23821202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.
    Philipp C; Edelmann J; Bühler A; Winkler D; Stilgenbauer S; Küppers R
    Int J Cancer; 2011 Apr; 128(7):1747-50. PubMed ID: 20533286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
    Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
    Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
    Novara F; Arcaini L; Merli M; Passamonti F; Zibellini S; Rizzi S; Rattotti S; Rumi E; Pascutto C; Vetro A; Astori C; Boveri E; Lucioni M; Paulli M; Zuffardi O; Lazzarino M
    Hum Pathol; 2009 Nov; 40(11):1628-37. PubMed ID: 19647853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multigene methylation analysis of ocular adnexal MALT lymphoma and their relationship to Chlamydophila psittaci infection and clinical characteristics in South Korea.
    Choung HK; Kim YA; Lee MJ; Kim N; Khwarg SI
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1928-35. PubMed ID: 22410569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
    Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
    van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
    Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.
    Braggio E; Dogan A; Keats JJ; Chng WJ; Huang G; Matthews JM; Maurer MJ; Law ME; Bosler DS; Barrett M; Lossos IS; Witzig TE; Fonseca R
    Mod Pathol; 2012 May; 25(5):651-60. PubMed ID: 22301699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
    Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
    Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia.
    Mannami T; Yoshino T; Oshima K; Takase S; Kondo E; Ohara N; Nakagawa H; Ohtsuki H; Harada M; Akagi T
    Mod Pathol; 2001 Jul; 14(7):641-9. PubMed ID: 11454995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-banding and molecular cytogenetic analyses of marginal zone lymphoma.
    Aamot HV; Micci F; Holte H; Delabie J; Heim S
    Br J Haematol; 2005 Sep; 130(6):890-901. PubMed ID: 16156859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.
    Hatem J; Schrank-Hacker AM; Watt CD; Morrissette JJ; Rubin AI; Kim EJ; Nasta SD; Wasik MA; Bogusz AM
    Diagn Pathol; 2016 Dec; 11(1):137. PubMed ID: 27993143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma.
    Bosga-Bouwer AG; Kok K; Booman M; Boven L; van der Vlies P; van den Berg A; van den Berg E; de Jong B; Poppema S; Kluin P
    Genes Chromosomes Cancer; 2006 Oct; 45(10):976-81. PubMed ID: 16865685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.